Nrf2 regulates chronic lung inflammation and B-cell responses to nontypeable Haemophilus influenzae

American Journal of Respiratory Cell and Molecular Biology

Volumn 45, Issue 3, 2011, Pages 557-565

  Lugade, Amit A ^a   Vethanayagam, R Robert ^a   Nasirikenari, Mehrab ^a   Bogner, Paul N ^a   Segal, Brahm H ^a   Thanavala, Yasmin ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

B cell responses; Lung inflammation; Nontypeable haemophilus influenzae; Nrf2

Indexed keywords

OUTER MEMBRANE PROTEIN; TRANSCRIPTION FACTOR NRF2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BACTERIUM IDENTIFICATION; CELL INFILTRATION; CHRONIC BRONCHITIS; CHRONIC INFLAMMATION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; GENOTYPE; HAEMOPHILUS INFLUENZAE; IMMUNOREGULATION; MOUSE; NONHUMAN; PLASMA CELL; RESPIRATORY TRACT INFLAMMATION;

ANIMALS; B-LYMPHOCYTES; BRONCHITIS; BRONCHOALVEOLAR LAVAGE; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; HAEMOPHILUS INFLUENZAE; IMMUNE SYSTEM; INFLAMMATION; LUNG; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, BIOLOGICAL; NF-E2-RELATED FACTOR 2;

BACTERIA (MICROORGANISMS); HAEMOPHILUS INFLUENZAE; MUS;

EID: 80052458479     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2010-0321OC     Document Type: Article

References (54)

1. Sethi S., Murphy T.F. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008;359:2355-2365.
2. Sethi S., Evans N., Grant B.J., Murphy T.F. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002;347:465-471. (Pubitemid 34879333)
3. Berenson C.S., Garlipp M.A., Grove L.J., Maloney J., Sethi S. Impaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary disease. J Infect Dis 2006;194:1375-1384. (Pubitemid 44706505)
4. Segal B.H., Han W., Bushey J.J., Joo M., Bhatti Z., Feminella J., Dennis C.G., Vethanayagam R.R., Yull F.E., Capitano M., et al. NADPH oxidase limits innate immune responses in the lungs in mice. PLoS ONE 2010;5:e9631.
5. Kensler T.W., Wakabayashi N., Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 2007;47:89-116.
6. Wakabayashi N., Itoh K., Wakabayashi J., Motohashi H., Noda S., Takahashi S., Imakado S., Kotsuji T., Otsuka F., Roop D.R., et al. Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat Genet 2003;35:238-245. (Pubitemid 37363177)
7. Cullinan S.B., Gordan J.D., Jin J., Harper J.W., Diehl J.A. The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: Oxidative stress sensing by a Cul3-Keap1 ligase. Mol Cell Biol 2004;24:8477-8486. (Pubitemid 39245070)
8. Higa L.A., Zhang H. Stealing the spotlight: CUL4-DDB1 ubiquitin ligase docks WD40-repeat proteins to destroy. Cell Div 2007;2:5.
9. Kobayashi A., Kang M.I., Okawa H., Ohtsuji M., Zenke Y., Chiba T., Igarashi K., Yamamoto M. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol 2004;24:7130-7139. (Pubitemid 39014439)
10. Rachakonda G., Xiong Y., Sekhar K.R., Stamer S.L., Liebler D.C., Freeman M.L. Covalent modification at Cys151 dissociates the electrophile sensor Keap1 from the ubiquitin ligase CUL3. Chem Res Toxicol 2008;21:705-710. (Pubitemid 351498046)
11. Thimmulappa R.K., Lee H., Rangasamy T., Reddy S.P., Yamamoto M., Kensler T.W., Biswal S. Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J Clin Invest 2006;116:984-995.
12. Rangasamy T., Guo J., Mitzner W.A., Roman J., Singh A., Fryer A.D., Yamamoto M., Kensler T.W., Tuder R.M., Georas S.N., et al. Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice. J Exp Med 2005;202:47-59. (Pubitemid 41002909)
13. Rangasamy T., Cho C.Y., Thimmulappa R.K., Zhen L., Srisuma S.S., Kensler T.W., Yamamoto M., Petrache I., Tuder R.M., Biswal S. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest 2004;114:1248-1259. (Pubitemid 40385296)
14. Lugade, A.A., Bogner P.N., Thanavala Y. Murine model of chronic respiratory inflammation. In Pulendran B, et al., editors. Crossroads between Innate and Adaptive Immunity: III. Advances in Experimental Medicine and Biology. Springer Science+Business Media; 2011.
15. Hogg J.C., Chu F., Utokaparch S., Woods R., Elliott W.M., Buzatu L., Cherniack R.M., Rogers R.M., Sciurba F.C., Coxson H.O., et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004;350:2645-2653. (Pubitemid 38787999)
16. Chan J.Y., Kwong M. Impaired expression of glutathione synthetic enzyme genes in mice with targeted deletion of the Nrf2 basic-leucine zipper protein. Biochim Biophys Acta 2000;1517:19-26.
17. Badr W.H., Loghmanee D., Karalus R.J., Murphy T.F., Thanavala Y. Immunization of mice with P6 of nontypeable Haemophilus influenzae: Kinetics of the antibody response and IgG subclasses. Vaccine 1999;18:29-37. (Pubitemid 29432135)
18. McMahon M., Murphy T.F., Kyd J., Thanavala Y. Role of an immunodominant T cell epitope of the P6 protein of nontypeable Haemophilus influenzae in murine protective immunity. Vaccine 2005;23:3590-3596. (Pubitemid 40602794)
19. Berenson C.S., Murphy T.F., Wrona C.T., Sethi S. Outer membrane protein P6 of nontypeable Haemophilus influenzae is a potent and selective inducer of human macrophage proinflammatory cytokines. Infect Immun 2005;73:2728-2735. (Pubitemid 40570338)
20. Kurita S., Koyama J., Onizuka S., Motomura K., Watanabe H., Watanabe K., Senba M., Apicella M.A., Murphy T.F., Yoneyama H., et al. Dynamics of dendritic cell migration and the subsequent induction of protective immunity in the lung after repeated airway challenges by nontypeable Haemophilus influenzae outer membrane protein. Vaccine 2006;24:5896-5903. (Pubitemid 43964973)
21. Lugade A.A., Bianchi A., Pradhan V., Elkin G., Murphy T.F., Thanavala Y. Lipid motif of a bacterial antigen mediates immune responses via TLR2 signaling. PLoS ONE 2011;6:e19781.
22. Ng L.G., Sutherland A.P., Newton R., Qian F., Cachero T.G., Scott M.L., Thompson J.S., Wheway J., Chtanova T., Groom J., et al. B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B-cells. J Immunol 2004;173:807-817. (Pubitemid 38924255)
23. Malhotra D., Thimmulappa R., Navas-Acien A., Sandford A., Elliott M., Singh A., Chen L., Zhuang X., Hogg J., Pare P., et al. Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1. Am J Respir Crit Care Med 2008;178:592-604.
24. Malhotra D., Thimmulappa R., Vij N., Navas-Acien A., Sussan T., Merali S., Zhang L., Kelsen S.G., Myers A., Wise R., et al. Heightened endoplasmic reticulum stress in the lungs of patients with chronic obstructive pulmonary disease: The role of Nrf2-regulated proteasomal activity. Am J Respir Crit Care Med 2009;180:1196-1207.
25. Suzuki M., Betsuyaku T., Ito Y., Nagai K., Nasuhara Y., Kaga K., Kondo S., Nishimura M. Down-regulated NF-E2-related factor 2 in pulmonary macrophages of aged smokers and patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2008;39:673-682.
26. Blake D.J., Singh A., Kombairaju P., Malhotra D., Mariani T.J., Tuder R.M., Gabrielson E., Biswal S. Deletion of Keap1 in the lung attenuates acute cigarette smoke-induced oxidative stress and inflammation. Am J Respir Cell Mol Biol 2010;42:524-536.
27. Singh A., Ling G., Suhasini A.N., Zhang P., Yamamoto M., Navas-Acien A., Cosgrove G., Tuder R.M., Kensler T.W., Watson W.H., et al. Nrf2-dependent sulfiredoxin-1 expression protects against cigarette smoke-induced oxidative stress in lungs. Free Radic Biol Med 2009;46:376-386.
28. Sussan T.E., Rangasamy T., Blake D.J., Malhotra D., El-Haddad H., Bedja D., Yates M.S., Kombairaju P., Yamamoto M., Liby K.T., et al. Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice. Proc Natl Acad Sci USA 2009;106:250-255.
29. Gaschler G.J., Skrtic M., Zavitz C.C., Lindahl M., Onnervik P.O., Murphy T.F., Sethi S., Stampfli M.R. Bacteria challenge in smoke-exposed mice exacerbates inflammation and skews the inflammatory profile. Am J Respir Crit Care Med 2009;179:666-675.
30. Rahman I. Antioxidant therapeutic advances in COPD. Ther Adv Respir Dis 2008;2:351-374.
31. Reddy N.M., Suryanarayana V., Kalvakolanu D.V., Yamamoto M., Kensler T.W., Hassoun P.M., Kleeberger S.R., Reddy S.P. Innate immunity against bacterial infection following hyperoxia exposure is impaired in NRF2-deficient mice. J Immunol 2009;183:4601-4608.
32. Mucida D., Park Y., Kim G., Turovskaya O., Scott I., Kronenberg M., Cheroutre H. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007;317:256-260. (Pubitemid 47076203)
33. Alcorn J.F., Crowe C.R., Kolls J.K. TH17 cells in asthma and COPD. Annu Rev Physiol 2010;72:495-516.
34. Ding C., Cai Y., Marroquin J., Ildstad S.T., Yan J. Plasmacytoid dendritic cells regulate autoreactive B cell activation via soluble factors and in a cell-to-cell contact manner. J Immunol 2009;183:7140-7149.
35. Shaw J., Wang Y.H., Ito T., Arima K., Liu Y.J. Plasmacytoid dendritic cells regulate B-cell growth and differentiation via CD70. Blood 2010;115:3051-3057.
36. Wan S., Zhou Z., Duan B., Morel L. Direct B cell stimulation by dendritic cells in a mouse model of lupus. Arthritis Rheum 2008;58:1741-1750. (Pubitemid 351847528)
37. Rangasamy T., Williams M.A., Bauer S., Trush M.A., Emo J., Georas S.N., Biswal S. Nuclear erythroid 2 p45-related factor 2 inhibits the maturation of murine dendritic cells by ragweed extract. Am J Respir Cell Mol Biol 2010;43:276-285.
38. Williams M.A., Rangasamy T., Bauer S.M., Killedar S., Karp M., Kensler T.W., Yamamoto M., Breysse P., Biswal S., Georas S.N. Disruption of the transcription factor Nrf2 promotes pro-oxidative dendritic cells that stimulate Th2-like immunoresponsiveness upon activation by ambient particulate matter. J Immunol 2008;181:4545-4559.
39. Kim H.J., Barajas B., Wang M., Nel A.E. Nrf2 activation by sulforaphane restores the age-related decrease of T(H)1 immunity: Role of dendritic cells. J Allergy Clin Immunol 2008;121:1255-1261.
40. Hogg J.C., Chu F.S., Tan W.C., Sin D.D., Patel S.A., Pare P.D., Martinez F.J., Rogers R.M., Make B.J., Criner G.J., et al. Survival after lung volume reduction in chronic obstructive pulmonary disease: Insights from small airway pathology. Am J Respir Crit Care Med 2007;176:454-459. (Pubitemid 47358099)
41. Van der Strate B.W., Postma D.S., Brandsma C.A., Melgert B.N., Luinge M.A., Geerlings M., Hylkema M.N., Van den Berg A., Timens W., Kerstjens H.A. Cigarette smoke-induced emphysema: A role for the B cell? Am J Respir Crit Care Med 2006;173:751-758.
42. Kelsen S.G., Aksoy M.O., Georgy M., Hershman R., Ji R., Li X., Hurford M., Solomides C., Chatila W., Kim V. Lymphoid follicle cells in chronic obstructive pulmonary disease overexpress the chemokine receptor CXCR3. Am J Respir Crit Care Med 2009;179:799-805.
43. Gosman M.M., Willemse B.W., Jansen D.F., Lapperre T.S., Van Schadewijk A., Hiemstra P.S., Postma D.S., Timens W., Kerstjens H.A. Increased number of B-cells in bronchial biopsies in COPD. Eur Respir J 2006;27:60-64. (Pubitemid 43092667)
44. Polverino F., Baraldo S., Bazzan E., Agostini S., Turato G., Lunardi F., Balestro E., Damin M., Papi A., Maestrelli P., et al. A novel insight into adaptive immunity in COPD: B cell activating factor belonging to the TNF family (BAFF). Am J Respir Crit Care Med 2010;182:1011-1019.
45. Majo J., Ghezzo H., Cosio M.G. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur Respir J 2001;17:946-953. (Pubitemid 32600344)
46. Moyron-Quiroz J.E., Rangel-Moreno J., Kusser K., Hartson L., Sprague F., Goodrich S., Woodland D.L., Lund F.E., Randall T.D. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat Med 2004;10:927-934. (Pubitemid 39273733)
47. Bancos S., Baglole C.J., Rahman I., Phipps R.P. Induction of heme oxygenase-1 in normal and malignant B lymphocytes by 15-deoxydelta(12,14)- prostaglandin J(2) requires Nrf2. Cell Immunol 2010;262:18-27.
48. Wu R.P., Hayashi T., Cottam H.B., Jin G., Yao S., Wu C.C., Rosenbach M.D., Corr M., Schwab R.B., Carson D.A. Nrf2 responses and the therapeutic selectivity of electrophilic compounds in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2010;107:7479-7484.
49. Bertolotti M., Yim S.H., Masciarelli S., Kim Y.J., Garcia-Manteiga J.M., Vené R., Iuchi Y., Kang M.H., Fujii J., Rubartelli A., et al. B to plasma cell terminal differentiation entails oxidative stress and profound reshaping of the antioxidant responses. Antioxid Redox Signal 2010;13:1133-1144.
50. Johnson D.A., Amirahmadi S., Ward C., Fabry Z., Johnson J.A. The absence of the pro-antioxidant transcription factor Nrf2 exacerbates experimental autoimmune encephalomyelitis. Toxicol Sci 2010;114:237-246.
51. Ma Q., Battelli L., Hubbs A.F. Multiorgan autoimmune inflammation, enhanced lymphoproliferation, and impaired homeostasis of reactive oxygen species in mice lacking the antioxidant-activated transcription factor Nrf2. Am J Pathol 2006;168:1960-1974. (Pubitemid 43825316)
52. Yoh K., Itoh K., Enomoto A., Hirayama A., Yamaguchi N., Kobayashi M., Morito N., Koyama A., Yamamoto M., Takahashi S. Nrf2-deficient female mice develop lupus-like autoimmune nephritis. Kidney Int 2001;60:1343-1353. (Pubitemid 32960028)
53. Morito N., Yoh K., Hirayama A., Itoh K., Nose M., Koyama A., Yamamoto M., Takahashi S. Nrf2 deficiency improves autoimmune nephritis caused by the fas mutation lpr. Kidney Int 2004;65:1703-1713. (Pubitemid 38591018)
54. Li J., Stein T.D., Johnson J.A. Genetic dissection of systemic autoimmune disease in Nrf2-deficient mice. Physiol Genomics 2004;18:261-272. (Pubitemid 39319509)